Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Turnover 307,634 More Arrow 355,527 Less Arrow 280,309
Financial expenses 18,697 More Arrow 27,090 Less Arrow 11,196
Earnings before taxes 20,672 Less Arrow -59,356 More Arrow -13,797
EBITDA 30,187 Less Arrow -18,131 More Arrow 12,800
Total assets 373,710 Less Arrow 355,936 More Arrow 413,118
Current assets 293,896 Less Arrow 270,829 More Arrow 332,943
Current liabilities 192,666 Less Arrow 133,358 More Arrow 332,301
Equity capital 28,554 Less Arrow -27,416 More Arrow 64,494
- share capital 13,697 More Arrow 14,208 More Arrow 15,694
Employees (average) 126 More Arrow 128 Less Arrow 124

Financial ratios

Fiscal year 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Solvency 7.6% Less Arrow -7.7% More Arrow 15.6%
Turnover per employee 2,442 More Arrow 2,778 Less Arrow 2,261
Profit as a percentage of turnover 6.7% Less Arrow -16.7% More Arrow -4.9%
Return on assets (ROA) 10.5% Less Arrow -9.1% More Arrow -0.6%
Current ratio 152.5% More Arrow 203.1% Less Arrow 100.2%
Return on equity (ROE) 72.4% More Arrow 216.5% Less Arrow -21.4%
Change turnover -35,105 More Arrow 101,766 Less Arrow -21,027
Change turnover % -10% More Arrow 40% Less Arrow -7%
Chg. No. of employees -2 More Arrow 4 Less Arrow -5
Chg. No. of employees % -2% More Arrow 3% Less Arrow -4%

Total value of public sale

Fiscal year 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.